Understanding Fibromyalgia and its Resultant Disability
Ivy Grodman, Dan Buskila MD, Yoav Arnson MD, Arie Altaman MD PhD, Daniela Amital MD MHA and Howard Amital MD MHA.
Department of Medicine B, Sheba Medical Center, Tel Hashomer, affiliated with Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel. Division of Internal Medicine, Department of Medicine H, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel and Department of Psychiatry, Ness Ziona Mental Health Center, Ness Ziona, Israel
IMAJ * VOL 13 * December 2011The introduction of the American College of Rheumatology fibromyalgia classification criteria 20 years ago heralded two decades of professional acceptance and enhanced multidisciplinary research in the pathogenesis and therapy of fibromyalgia [1]. Whereas the initial criteria included tenderness on pressure (tender points) in at least 11 of 18 defined anatomic sites with the presence of widespread pain, in the 2010 set of proposed criteria it is clear that apart from the pain other seminal features of the disorder - namely cognitive dysfunction, unrefreshing sleep, fatigue and mood disorders -play an important role in the diagnosis [2]. Many journals today dedicate scientific papers to the pathogenesis and treatment of fibromyalgia, and grants are provided worldwide to investigate the disorder.
http://www.ima.org.il/imaj/ar11Dec-12.pdf 
No hay comentarios:
Publicar un comentario